Head-to-head · Cost-Efficiency Index
Amble vs Aspen
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Amble
Cost-first shoppers who want a single flat rate across semaglutide and tirzepatide, if a 12-month prepay is acceptable.
Visit AmbleAspen
Cost-first shoppers who want wanting one flat price regardless of whether treatment ends up being semaglutide or tirzepatide, if willing to commit to 3 months.
Visit AspenThe verdict
Amble and Aspen tie on the Cost-Efficiency Index at 74/100, so neither wins outright on the numbers. For most shoppers we'd start with Amble (ranked #56, a hair above #57) — Cost-first shoppers who want a single flat rate across semaglutide and tirzepatide, if a 12-month prepay is acceptable. But Aspen is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Amble.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Amble | Aspen |
|---|---|---|
| Cost-Efficiency Index | 74/100 | 74/100 |
| Semaglutide / mo | $179/mo (all doses, compounded) | $179/mo (all doses, compounded) |
| Tirzepatide / mo | $179/mo (all doses, compounded) | $179/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,148 | $2,148 |
| Tirzepatide / yr (modeled) | $2,148 | $2,148 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #56 | #57 |
Amble
74/100Where the value is
- No difference in price between semaglutide and tirzepatide — genuinely one pricing table for both
- True no-commitment option exists ($179/mo, pay as you go) alongside the prepay tiers
- All 50 states, with only 5 requiring a live video visit instead of async intake
The tradeoffs
- The advertised low-end price ($135-$160/mo) is not a monthly bill — it's a one-time lump-sum prepay for the whole 3/6/12-month term, stated explicitly on the page
- No named medical director, prescriber, or compounding pharmacy anywhere on the site
Aspen
74/100Where the value is
- One transparent, dose-independent flat price ($179/mo) covers either the semaglutide or tirzepatide path, avoiding the tirzepatide surcharge most compounded competitors charge
- Price stated to be all-in: provider consultation, custom dosing, medication, and free delivery bundled with no listed add-on fees
- No insurance required, cash-pay simplicity
The tradeoffs
- The bold '$179/mo' headline omits its own fine-print condition — a 3-month commitment — visible only in small text directly beneath the price
- Almost nothing else is disclosed on the public site: no states-served list, no named medical director or prescriber, no named pharmacy, and no LegitScript certification found
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.